Christopher Brett Primiano, SVP, Operations, Business Development, GC & Secretary at Karyopharm Therapeutics Inc. (KPTI), sold 805 shares at $10.03 ($8K) on 2017-06-26, disclosed to the SEC on 2017-09-01.
Scheduled sale ($8k) by SVP, Operations, Business Development, GC & Secretary under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KPTI | SELL | 2020-10-14 | $1.3M | — | Filing → |
| KPTI | SELL | 2020-09-10 | $301K | — | Filing → |
| KPTI | SELL | 2020-05-11 | $322K | — | Filing → |